Duchenne's Muscular Dystrophy (DMD) Completed Phase 2 Trials for Ataluren (DB05016)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02819557Study of Ataluren in ≥2 to <5 Year-Old Males With Duchenne Muscular DystrophyTreatment
NCT00592553Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)Treatment
NCT00264888Safety and Efficacy Study of PTC124 in Duchenne Muscular DystrophyTreatment